Aurora Cannabis Inc. (TSX/NASDAQ:ACB), a Canadian-based global medical cannabis company, reported its financial and operational results for the fourth quarter and full fiscal year ending March 31, 2026. The company delivered strong performance across key metrics, achieving record annual global medical cannabis net revenue of C$288.6 million, marking an 18 per cent increase year over year. It also generated record annual adjusted EBITDA of C$53.8 million, reflecting a 32 per cent improvement compared to the previous year.
In addition to its financial growth, Aurora strengthened its strategic position by completing the acquisition of Safari Flower Company in April, an established EU-GMP-certified manufacturer. This acquisition enhances the company’s production capabilities and supports expansion in high-growth international markets. Aurora also maintained a solid financial position, ending the period with approximately C$164.7 million in cash, short-term investments, and cash equivalents, while carrying no debt on its balance sheet.
Click here for the full story.
Top cannabis news stories
1 | Trulieve announces uplist to NYSE
2 | Herbal Dispatch completes 452kg multi-client medical cannabis export shipment to Europe
3 | Canopy Growth announces Claybourne’s Frosted Flyers wins ‘Best Infused Pre-Roll’ at 2026 Grow Up Awards
Top Cannabis Stocks June 5 to June 11, 2026
1. T.CURA | 7,309 views | Curaleaf Holdings Inc.
2. T.TLRY | 2,405 views | Tilray Brands Inc.
3. T.LABS | 1,899 views | Medipharm Labs Corp.
4. T.OGI | 502 views | Organigram Global Inc.
5. C.TGIF | 382 views | 1933 Industries Inc.
6. C.BLO | 283 views | Cannabix Technologies Inc.
